CAS: 912999-49-6 - Onalespib
Formula:C24H31N3O3
InChI:InChI=1S/C24H31N3O3/c1-16(2)20-11-21(23(29)12-22(20)28)24(30)27-14-18-5-4-17(10-19(18)15-27)13-26-8-6-25(3)7-9-26/h4-5,10-12,16,28-29H,6-9,13-15H2,1-3H3
InChI key:InChIKey=IFRGXKKQHBVPCQ-UHFFFAOYSA-N
SMILES:O=C(C=1C=C(C(O)=CC1O)C(C)C)N2CC3=CC=C(C=C3C2)CN4CCN(C)CC4
- Synonyms:
- (2,4-Dihydroxy-5-isopropylphenyl)[5-[(4-methylpiperazin-1-yl)methyl]-1,3-dihydroisoindol-2-yl]methanone
- (2,4-Dihydroxy-5-propan-2-ylphenyl)-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-dihydroisoindol-2-yl]methanone
- 1H-Isoindole, 2-[2,4-dihydroxy-5-(1-methylethyl)benzoyl]-2,3-dihydro-5-[(4-methyl-1-piperazinyl)methyl]-
- At 13387X
- At-13387
- Ati 3387
- Methanone, [1,3-dihydro-5-[(4-methyl-1-piperazinyl)methyl]-2H-isoindol-2-yl][2,4-dihydroxy-5-(1-methylethyl)phenyl]-
- [1,3-Dihydro-5-[(4-methyl-1-piperazinyl)methyl]-2H-isoindol-2-yl][2,4-dihydroxy-5-(1-methylethyl)phenyl]methanone
(2,4-dihydroxy-5-isopropylphenyl)(5-((4-Methylpiperazin-1-yl)Methyl)isoindolin-2-yl)Methanone
CAS:912999-49-6
Formula:
C24H31N3O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
409.5212
Ref: IN-DA00GU12
5mg | 97.00 € | ||
10mg | 140.00 € | ||
50mg | 468.00 € | ||
100mg | 502.00 € | ||
250mg | To inquire |
Estimated delivery in United States, on Wednesday 4 Dec 2024
Onalespib
CAS:912999-49-6
Onalespib (AT13387) is an oral Hsp90 inhibitor with anticancer potential, disrupting tumor cell growth and …
Formula:
C24H31N3O3
Purity:
98.05% - 99.82%
Color and Shape:
Solid
Molecular weight:
409.52
Ref: TM-T6284
1mg | 45.00 € | ||
5mg | 87.00 € | ||
10mg | 156.00 € | ||
25mg | 247.00 € | ||
50mg | 353.00 € | ||
100mg | 522.00 € | ||
500mg | 1,142.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
AT-13387
CAS:912999-49-6
AT-13387 is a potent and selective HSP90 inhibitor that binds to the ATP binding site …
Purity:
Min. 95%
Ref: 3D-FA145338
5mg | 172.00 € | ||
10mg | 248.00 € | ||
25mg | 436.00 € | ||
50mg | 582.00 € | ||
100mg | 863.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025